Home » Topics » BioWorld Science

BioWorld Science
RSS

New MAP3K5 inhibitors discovered at CJ HealthCare

May 11, 2020

New phase I trial evaluates gene therapy to treat severe hemophilia A

May 11, 2020

Boehringer Ingelheim identifies new NR2B receptor negative allosteric modulators

May 11, 2020

Cell competition links hyperinsulinemia to cancer

May 11, 2020

First-in-human results presented for SLC-0111 in advanced solid tumors

May 11, 2020

SNYE1 mutations associated with cerebellar ataxia and generalized dystonia

May 11, 2020

Health Canada grants approval for phase II study of LSALT peptide in patients with COVID-19

May 11, 2020

FDA clears IND application for phase II study of PLX cells in severe COVID-19

May 11, 2020

FDA approves IND for phase IIa study of opaganib for COVID-19

May 11, 2020

Cynata receives ethics approval for MEND study of Cymerus MSCs in COVID-19

May 11, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...